The transcriptome signature of HT29-cocultured MCs potentially reflects the mechanism of how colon cancer cells may shape MCs to become a pro-tumor player in the early phase and how a subsequent inflammatory signal (e.g., TLR2 ligands) may modify their responses in the cancer milieu. The gene discussed is TLR2; the disease is malignant colon neoplasm.